Dr. Nadeem N Dhanani, MD,MPH
Claim this profileMore about Nadeem N Dhanani, MD,MPH
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Nadeem N Dhanani, MD,MPH has experience with
- Antegrade Nephrostomy
- Retrograde Nephrostomy
Breakdown of trials Nadeem N Dhanani, MD,MPH has run
Struvite Kidney Stones
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Nadeem N Dhanani, MD,MPH specialize in?
Nadeem N Dhanani, MD,MPH focuses on Struvite Kidney Stones and Kidney Stones. In particular, much of their work with Struvite Kidney Stones has involved treating patients, or patients who are undergoing treatment.
Is Nadeem N Dhanani, MD,MPH currently recruiting for clinical trials?
No, Nadeem N Dhanani, MD,MPH is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Nadeem N Dhanani, MD,MPH has studied deeply?
Yes, Nadeem N Dhanani, MD,MPH has studied treatments such as Antegrade Nephrostomy, Retrograde Nephrostomy.
What is the best way to schedule an appointment with Nadeem N Dhanani, MD,MPH?
Apply for one of the trials that Nadeem N Dhanani, MD,MPH is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.